Anand P. Gupta

1.1k total citations
28 papers, 785 citations indexed

About

Anand P. Gupta is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Anand P. Gupta has authored 28 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Physiology and 7 papers in Epidemiology. Recurrent topics in Anand P. Gupta's work include Adipose Tissue and Metabolism (8 papers), Metabolism, Diabetes, and Cancer (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Anand P. Gupta is often cited by papers focused on Adipose Tissue and Metabolism (8 papers), Metabolism, Diabetes, and Cancer (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Anand P. Gupta collaborates with scholars based in India, United States and Poland. Anand P. Gupta's co-authors include Richard C Lewontin, Jiaur R. Gayen, Mohammed Riyazuddin, Syed Anees Ahmed, Guru R. Valicherla, Pragati Singh, Zakir Hossain, Kandarp M. Dave, Athar Husain and Muhammad Wahajuddin and has published in prestigious journals such as Scientific Reports, Evolution and Journal of Neurochemistry.

In The Last Decade

Anand P. Gupta

28 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anand P. Gupta India	16	219	148	140	132	115	28	785
Alejandro D. Bolzán Argentina	17	676 3.1×	199 1.3×	320 2.3×	45 0.3×	47 0.4×	60	1.5k
Daniel M. Saidemberg Brazil	13	336 1.5×	144 1.0×	90 0.6×	27 0.2×	46 0.4×	22	789
Yasuyuki Suzuki Japan	21	242 1.1×	54 0.4×	230 1.6×	151 1.1×	15 0.1×	50	1.1k
T. D. McKinney United States	21	713 3.3×	40 0.3×	100 0.7×	68 0.5×	31 0.3×	51	1.4k
Somanshu Banerjee India	17	181 0.8×	72 0.5×	55 0.4×	42 0.3×	27 0.2×	38	737
Fariba M. Assadi‐Porter United States	20	883 4.0×	66 0.4×	327 2.3×	50 0.4×	198 1.7×	41	1.7k
Mária Péter Hungary	18	650 3.0×	38 0.3×	240 1.7×	24 0.2×	66 0.6×	47	1.2k
Miguel W. Fornés Argentina	20	337 1.5×	165 1.1×	143 1.0×	29 0.2×	45 0.4×	54	1.5k
William L. Banks United States	14	149 0.7×	68 0.5×	170 1.2×	28 0.2×	54 0.5×	27	701
Aleksandra Čvoro United States	19	775 3.5×	518 3.5×	225 1.6×	17 0.1×	128 1.1×	33	1.6k

Countries citing papers authored by Anand P. Gupta

Since Specialization

Citations

This map shows the geographic impact of Anand P. Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand P. Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand P. Gupta more than expected).

Fields of papers citing papers by Anand P. Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anand P. Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand P. Gupta. The network helps show where Anand P. Gupta may publish in the future.

Co-authorship network of co-authors of Anand P. Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Anand P. Gupta. A scholar is included among the top collaborators of Anand P. Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anand P. Gupta. Anand P. Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verma, Saurabh, et al.. (2022). Pancreastatin inhibitor PSTi8 balances energy homeostasis by attenuating adipose tissue inflammation in high fat diet fed mice. Peptides. 159. 170902–170902. 4 indexed citations

Garg, Richa, et al.. (2021). Pancreastatin inhibitor PSTi8 prevents free fatty acid-induced oxidative stress and insulin resistance by modulating JNK pathway: In vitro and in vivo findings. Life Sciences. 289. 120221–120221. 9 indexed citations

Gupta, Jyoti, Dharmendra Singh, Neha Rahuja, et al.. (2021). Pregnane-Oximino-Alkyl-Amino-Ether Compound as a Novel Class of TGR5 Receptor Agonist Exhibiting Antidiabetic and Anti-Dyslipidemic Activities. Pharmacology. 107(1-2). 54–68. 4 indexed citations

Singh, Pragati, Mohammad Irshad Reza, Syed Anees Ahmed, et al.. (2020). PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1/SREBP-1c axis. Heliyon. 6(12). e05826–e05826. 15 indexed citations

Singh, Pragati, Mohammed Riyazuddin, Mohammad Irshad Reza, et al.. (2020). Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice. Heliyon. 6(10). e05133–e05133. 19 indexed citations

Gupta, Anand P., Pragati Singh, Syed Anees Ahmed, et al.. (2020). Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice. European Journal of Pharmacology. 881. 173204–173204. 11 indexed citations

Kumar, Amit, Natasha Jaiswal, Chandan K. Maurya, et al.. (2019). Fructose-induced AGEs-RAGE signaling in skeletal muscle contributes to impairment of glucose homeostasis. The Journal of Nutritional Biochemistry. 71. 35–44. 24 indexed citations

Gupta, Anand P., Syed Anees Ahmed, Pragati Singh, et al.. (2019). Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway. European Journal of Pharmacology. 864. 172723–172723. 21 indexed citations

Riyazuddin, Mohammed, Athar Husain, Guru R. Valicherla, et al.. (2019). Development and validation of LC-MS/MS method for quantification of novel PP2A – β-catenin signalling inhibitor, S011-2111 in mice plasma: Application to its preclinical pharmacokinetic studies. Journal of Chromatography B. 1130-1131. 121829–121829. 5 indexed citations

10.

Valicherla, Guru R., Anand P. Gupta, Zakir Hossain, et al.. (2019). Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT/GSK-3β and PKCλ/ζ/SREBP1c pathways in high fat diet induced insulin resistance in peri-/post-menopausal rats. Peptides. 120. 170147–170147. 19 indexed citations

11.

Shankar, Kripa, Durgesh Kumar, Salil Varshney, et al.. (2019). Role of brown adipose tissue in modulating adipose tissue inflammation and insulin resistance in high-fat diet fed mice. European Journal of Pharmacology. 854. 354–364. 49 indexed citations

12.

Hossain, Zakir, Guru R. Valicherla, Anand P. Gupta, et al.. (2018). Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus. Scientific Reports. 8(1). 8715–8715. 33 indexed citations

13.

Kushwaha, Rajesh, Anand P. Gupta, Naibedya Chattopadhyay, et al.. (2018). Rosiglitazone up‐regulates glial fibrillary acidic protein via HB‐EGF secreted from astrocytes and neurons through PPARγ pathway and reduces apoptosis in high‐fat diet‐fed mice. Journal of Neurochemistry. 149(5). 679–698. 19 indexed citations

14.

Riyazuddin, Mohammed, Guru R. Valicherla, Athar Husain, et al.. (2018). Elucidation of pharmacokinetics of novel DNA ligase I inhibitor, S012-1332 in rats: Integration of in vitro and in vivo findings. Journal of Pharmaceutical and Biomedical Analysis. 162. 205–214. 10 indexed citations

15.

Pathak, Priya, Deepika Awasthi, Anand P. Gupta, et al.. (2018). Glucose and lipid metabolism alterations in liver and adipose tissue pre-dispose p47^phox knockout mice to systemic insulin resistance. Free Radical Research. 52(5). 568–582. 10 indexed citations

16.

Pathak, Priya, et al.. (2017). Altered glucose and lipid homeostasis in liver and adipose tissue pre-dispose inducible NOS knockout mice to insulin resistance. Scientific Reports. 7(1). 41009–41009. 34 indexed citations

17.

Gupta, Anand P., Amit Kumar, Aditya Sharma, et al.. (2017). Isoalantolactone derivative promotes glucose utilization in skeletal muscle cells and increases energy expenditure in db/db mice via activating AMPK-dependent signaling. Molecular and Cellular Endocrinology. 460. 134–151. 20 indexed citations

18.

Ahmed, Syed Anees, Divya Mohan, Guru R. Valicherla, et al.. (2016). Cardioprotective Effect of Ulmus wallichiana Planchon in β-Adrenergic Agonist Induced Cardiac Hypertrophy. Frontiers in Pharmacology. 7. 510–510. 26 indexed citations

19.

Ahmed, Syed Anees, Divya Mohan, Guru R. Valicherla, et al.. (2016). Evaluation of anti-hypertensive activity of Ulmus wallichiana extract and fraction in SHR, DOCA-salt- and L-NAME-induced hypertensive rats. Journal of Ethnopharmacology. 193. 555–565. 30 indexed citations

20.

Valicherla, Guru R., Kandarp M. Dave, Syed Anees Ahmed, et al.. (2016). Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity. Scientific Reports. 6(1). 26895–26895. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact